世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000032893

キニジン硫酸塩の世界市場(2022-2026)

TechNavio

Global Quinidine Sulfate Market 2022-2026

発刊日 2022/08/12

言語英語

体裁PDF/120ページ

ライセンス/価格120ページ

0000032893

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、キニジン硫酸塩市場を分析します。

世界のキニジン硫酸塩市場は、予測期間中に約6.7 %のCAGRで推移し、2022年から2026年の間に4億2,729万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。

本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。マラリアの発生率の増加、強力なパイプラインと医薬品承認、M&Aの増加などが市場を牽引しています。

調査範囲

  • 市場セグメント
    ➣ タイプ別
      ◇ マラリア
      ◇ 不整脈
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ その他の地域

本調査では、今後数年間におけるキニジン硫酸塩市場の成長を促進する主要な理由の一つとして、マラリア撲滅のための強力な資金調達を挙げています。また、不整脈の発生率の増加や、キニジン硫酸塩サプリメントに関する人々の意識の高まりも、市場の大きな需要につながるでしょう。

TechNavio社は、主要なパラメーターの分析による複数のソースからのデータの調査、合成、および合計によって、市場の詳細な状況を提示します。

本レポートは以下の分野をカバーしています。

  • キニジン硫酸塩の市場規模
  • キニジン硫酸塩の市場予測
  • キニジン硫酸塩市場の業界分析

TechNavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要なキニジン硫酸塩市場ベンダーの詳細な分析を提供します

  • 調査企業
    ➣ Bennet Pharmaceuticals Ltd.
    ➣ Buchler GmbH, Cipla Ltd.
    ➣ Ipca Laboratories Ltd
    ➣ Lark Laboratories India Ltd.
    ➣ Merck and Co. Inc.
    ➣ Merck KGaA
    ➣ PRISM INDUSTRIES LTD.
    ➣ Teva Pharmaceutical Industries Ltd.
    ➣ VIVAN Life Sciences Pvt. Ltd.
    ➣ Biophore India Pharmaceuticals Pvt. Ltd.
    ➣ Inga Laboratories P. Ltd.
    ➣ Koninklijke DSM NV
    ➣ PMC Group Inc.
    ➣ PT Bio Farma
    ➣ PT Sinkona Indonesia lestar
    ➣ Vital Laboratories Pvt. Ltd.

また、本レポートには、市場の成長に影響を与える今後の動向と課題に関する情報が含まれており、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。

TechNavio社について

TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。TechNavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Disease Type
5.1 Market segments
Exhibit 24: Chart on Disease Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Disease Type - Market share 2021-2026 (%)
5.2 Comparison by Disease Type
Exhibit 26: Chart on Comparison by Disease Type
Exhibit 27: Data Table on Comparison by Disease Type
5.3 Malaria - Market size and forecast 2021-2026
Exhibit 28: Chart on Malaria - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Malaria - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Malaria - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Malaria - Year-over-year growth 2021-2026 (%)
5.4 Arrhythmias - Market size and forecast 2021-2026
Exhibit 32: Chart on Arrhythmias - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Arrhythmias - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Arrhythmias - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Arrhythmias - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Disease Type
Exhibit 36: Market opportunity by Disease Type ($ million)

6 Customer Landscape
6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 China - Market size and forecast 2021-2026
Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
7.10 UK - Market size and forecast 2021-2026
Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.11 Canada - Market size and forecast 2021-2026
Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business

10 Vendor Analysis
10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 Bennet Pharmaceuticals Ltd.
Exhibit 85: Bennet Pharmaceuticals Ltd. - Overview
Exhibit 86: Bennet Pharmaceuticals Ltd. - Product / Service
Exhibit 87: Bennet Pharmaceuticals Ltd. - Key offerings
10.4 Buchler GmbH
Exhibit 88: Buchler GmbH - Overview
Exhibit 89: Buchler GmbH - Product / Service
Exhibit 90: Buchler GmbH - Key offerings
10.5 Cipla Ltd.
Exhibit 91: Cipla Ltd. - Overview
Exhibit 92: Cipla Ltd. - Business segments
Exhibit 93: Cipla Ltd. - Key news
Exhibit 94: Cipla Ltd. - Key offerings
Exhibit 95: Cipla Ltd. - Segment focus
10.6 Ipca Laboratories Ltd.
Exhibit 96: Ipca Laboratories Ltd. - Overview
Exhibit 97: Ipca Laboratories Ltd. - Product / Service
Exhibit 98: Ipca Laboratories Ltd. - Key offerings
10.7 Lark Laboratories India Ltd.
Exhibit 99: Lark Laboratories India Ltd. - Overview
Exhibit 100: Lark Laboratories India Ltd. - Product / Service
Exhibit 101: Lark Laboratories India Ltd. - Key offerings
10.8 Merck and Co. Inc.
Exhibit 102: Merck and Co. Inc. - Overview
Exhibit 103: Merck and Co. Inc. - Business segments
Exhibit 104: Merck and Co. Inc. - Key news
Exhibit 105: Merck and Co. Inc. - Key offerings
Exhibit 106: Merck and Co. Inc. - Segment focus
10.9 Merck KGaA
Exhibit 107: Merck KGaA - Overview
Exhibit 108: Merck KGaA - Business segments
Exhibit 109: Merck KGaA - Key news
Exhibit 110: Merck KGaA - Key offerings
Exhibit 111: Merck KGaA - Segment focus
10.10 PRISM INDUSTRIES LTD.
Exhibit 112: PRISM INDUSTRIES LTD. - Overview
Exhibit 113: PRISM INDUSTRIES LTD. - Product / Service
Exhibit 114: PRISM INDUSTRIES LTD. - Key offerings
10.11 Teva Pharmaceutical Industries Ltd.
Exhibit 115: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 116: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 117: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 118: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 119: Teva Pharmaceutical Industries Ltd. - Segment focus
10.12 VIVAN Life Sciences Pvt. Ltd.
Exhibit 120: VIVAN Life Sciences Pvt. Ltd. - Overview
Exhibit 121: VIVAN Life Sciences Pvt. Ltd. - Product / Service
Exhibit 122: VIVAN Life Sciences Pvt. Ltd. - Key offerings

11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 123: Inclusions checklist
Exhibit 124: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 125: Currency conversion rates for US$
11.4 Research methodology
Exhibit 126: Research methodology
Exhibit 127: Validation techniques employed for market sizing
Exhibit 128: Information sources
11.5 List of abbreviations
Exhibit 129: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Disease Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Disease Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Disease Type
Exhibits27: Data Table on Comparison by Disease Type
Exhibits28: Chart on Malaria - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Malaria - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Malaria - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Malaria - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Arrhythmias - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Arrhythmias - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Arrhythmias - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Arrhythmias - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Disease Type ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Bennet Pharmaceuticals Ltd. - Overview
Exhibits86: Bennet Pharmaceuticals Ltd. - Product / Service
Exhibits87: Bennet Pharmaceuticals Ltd. - Key offerings
Exhibits88: Buchler GmbH - Overview
Exhibits89: Buchler GmbH - Product / Service
Exhibits90: Buchler GmbH - Key offerings
Exhibits91: Cipla Ltd. - Overview
Exhibits92: Cipla Ltd. - Business segments
Exhibits93: Cipla Ltd. - Key news
Exhibits94: Cipla Ltd. - Key offerings
Exhibits95: Cipla Ltd. - Segment focus
Exhibits96: Ipca Laboratories Ltd. - Overview
Exhibits97: Ipca Laboratories Ltd. - Product / Service
Exhibits98: Ipca Laboratories Ltd. - Key offerings
Exhibits99: Lark Laboratories India Ltd. - Overview
Exhibits100: Lark Laboratories India Ltd. - Product / Service
Exhibits101: Lark Laboratories India Ltd. - Key offerings
Exhibits102: Merck and Co. Inc. - Overview
Exhibits103: Merck and Co. Inc. - Business segments
Exhibits104: Merck and Co. Inc. - Key news
Exhibits105: Merck and Co. Inc. - Key offerings
Exhibits106: Merck and Co. Inc. - Segment focus
Exhibits107: Merck KGaA - Overview
Exhibits108: Merck KGaA - Business segments
Exhibits109: Merck KGaA - Key news
Exhibits110: Merck KGaA - Key offerings
Exhibits111: Merck KGaA - Segment focus
Exhibits112: PRISM INDUSTRIES LTD. - Overview
Exhibits113: PRISM INDUSTRIES LTD. - Product / Service
Exhibits114: PRISM INDUSTRIES LTD. - Key offerings
Exhibits115: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits116: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits117: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits118: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits119: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits120: VIVAN Life Sciences Pvt. Ltd. - Overview
Exhibits121: VIVAN Life Sciences Pvt. Ltd. - Product / Service
Exhibits122: VIVAN Life Sciences Pvt. Ltd. - Key offerings
Exhibits123: Inclusions checklist
Exhibits124: Exclusions checklist
Exhibits125: Currency conversion rates for US$
Exhibits126: Research methodology
Exhibits127: Validation techniques employed for market sizing
Exhibits128: Information sources
Exhibits129: List of abbreviations

この商品のレポートナンバー

0000032893

TOP